Keystone Financial Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,569
Closed -$1.98M 43
2025
Q4
$1.98M Sell
9,569
-67
-0.7% -$13.2K 0.57% 26
2025
Q3
$1.79M Hold
9,636
0.52% 28
2025
Q2
$1.47M Sell
9,636
-364
-4% -$56K 0.45% 28
2025
Q1
$1.66M Hold
10,000
0.49% 30
2024
Q4
$1.45M Hold
10,000
0.45% 32
2024
Q3
$1.62M Hold
10,000
0.49% 30
2024
Q2
$1.46M Sell
10,000
-145
-1% -$21.6K 0.48% 32
2024
Q1
$1.6M Sell
10,145
-415
-4% -$66.1K 0.52% 33
2023
Q4
$1.66M Sell
10,560
-94
-0.9% -$14.4K 0.55% 33
2023
Q3
$1.66M Sell
10,654
-176
-2% -$29K 0.58% 33
2023
Q2
$1.79M Buy
10,830
+144
+1% +$23.2K 0.6% 32
2023
Q1
$1.66M Sell
10,686
-324
-3% -$52.3K 0.56% 32
2022
Q4
$1.95M Sell
11,010
-64
-0.6% -$11.1K 0.66% 32
2022
Q3
$1.81M Sell
11,074
-370
-3% -$62.6K 0.7% 32
2022
Q2
$2.03M Sell
11,444
-1,133
-9% -$202K 0.71% 34
2022
Q1
$2.23M Sell
12,577
-395
-3% -$67.2K 0.75% 34
2021
Q4
$2.22M Sell
12,972
-118
-0.9% -$19.3K 0.76% 33
2021
Q3
$2.11M Sell
13,090
-336
-3% -$57.3K 0.77% 30
2021
Q2
$2.21M Sell
13,426
-265
-2% -$43.9K 0.8% 28
2021
Q1
$2.25M Sell
13,691
-310
-2% -$50.2K 0.84% 27
2020
Q4
$2.2M Sell
14,001
-8
-0.1% -$1.18K 0.91% 26
2020
Q3
$2.09M Hold
14,009
1.01% 27
2020
Q2
$1.97M Hold
14,009
0.97% 32
2020
Q1
$1.84M Sell
14,009
-19,048
-58% -$2.7M 1.05% 30
2019
Q4
$4.82M Sell
33,057
-454
-1% -$61.6K 2.15% 25
2019
Q3
$4.34M Buy
33,511
+1,994
+6% +$263K 2.07% 27
2019
Q2
$4.39M Sell
31,517
-165
-0.5% -$22.8K 2.15% 25
2019
Q1
$4.43M Sell
31,682
-79
-0.2% -$10.6K 2.19% 24
2018
Q4
$4.1M Buy
31,761
+493
+2% +$68.8K 2.29% 25
2018
Q3
$4.32M Buy
31,268
+439
+1% +$58.3K 2.21% 26
2018
Q2
$3.74M Sell
30,829
-910
-3% -$114K 2.06% 26
2018
Q1
$4.07M Sell
31,739
-1,956
-6% -$264K 2.27% 23
2017
Q4
$4.71M Buy
33,695
+56
+0.2% +$7.8K 2.51% 19
2017
Q3
$4.37M Buy
33,639
+670
+2% +$88.8K 2.48% 22
2017
Q2
$4.36M Buy
32,969
+529
+2% +$67.5K 2.64% 20
2017
Q1
$4.04M Buy
32,440
+311
+1% +$37.2K 2.51% 22
2016
Q4
$3.7M Sell
32,129
-1,203
-4% -$139K 2.42% 25
2016
Q3
$3.94M Buy
33,332
+94
+0.3% +$11.4K 2.59% 22
2016
Q2
$4.03M Buy
33,238
+441
+1% +$50.1K 2.73% 21
2016
Q1
$3.55M Sell
32,797
-5,040
-13% -$522K 2.54% 22
2015
Q4
$3.89M Sell
37,837
-399
-1% -$40.1K 2.94% 20
2015
Q3
$3.57M Buy
38,236
+114
+0.3% +$11K 2.88% 23
2015
Q2
$3.71M Buy
38,122
+9,591
+34% +$960K 2.84% 23
2015
Q1
$2.87M Sell
28,531
-1,059
-4% -$108K 2.18% 27
2014
Q4
$3.09M Sell
29,590
-61
-0.2% -$6.43K 2.28% 25
2014
Q3
$3.16M Sell
29,651
-13,324
-31% -$1.38M 2.39% 25
2014
Q2
$4.5M Sell
42,975
-5,937
-12% -$600K 3.39% 16
2014
Q1
$4.8M Buy
48,912
+1,460
+3% +$135K 3.72% 7
2013
Q4
$4.35M Buy
+47,452
New +$4.37M 3.48% 6

Other funds holding JNJ

Keystone Financial Planning's JNJ Position: Q1 2026 in Review

Keystone Financial Planning sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 9,569 shares — an estimated $1.98M sold.

Keystone Financial Planning first reported a position in JNJ in Q4 2013 and held it in 49 quarters. The position peaked at $4.82M in Q4 2019. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Keystone Financial Planning reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Keystone Financial Planning sold 9,569 Johnson & Johnson shares in Q1 2026, an estimated $1.98M.
  • Keystone Financial Planning first reported a position in Johnson & Johnson in Q4 2013 and held it in 49 quarters.
  • Keystone Financial Planning's Johnson & Johnson position peaked at $4.82M in Q4 2019.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Keystone Financial Planning's 13F filing for Q1 2026, filed 9 Apr 2026.